In the BioHarmony Drug Report Database
Diethylcarbamazine
Hetrazan (diethylcarbamazine) is a small molecule pharmaceutical. Diethylcarbamazine was first approved as Hetrazan on 1982-01-01. It is used to treat filarial elephantiasis, loiasis, and pulmonary eosinophilia in the USA.
Trade Name
|
Hetrazan |
|---|---|
Common Name
|
diethylcarbamazine |
ChEMBL ID
|
CHEMBL684 |
Indication
|
filarial elephantiasis, loiasis, pulmonary eosinophilia |
Drug Class
|
Image (chem structure or protein)